Abstract
What have been some of the past year's key events and trends for the biopharma industry?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
NEJM 356, 2457–2471 (2007).
Nature Rev. Drug Discov . 6, 505–506 (2007).
Nature Rev. Drug Discov . 6, 855–856 (2007).
Nature Rev. Drug Discov . 6, 769–771 (2007).
FDA subcommittee report [online], (2007).
Nature Rev. Drug Discov . 6, 688–689 (2007).
Nature Rev. Drug Discov . 6, 437–442 (2007).
Nature Rev. Drug Discov . 6, 590–591 (2007).
Nature Rev. Drug Discov . 6, 770–771 (2007).
Nature Rev. Drug Discov . 6, 945 (2007).
Rights and permissions
About this article
Cite this article
Hughes, B. 2007: Spotlight on drug safety. Nat Rev Drug Discov 7, 5–7 (2008). https://doi.org/10.1038/nrd2503
Issue Date:
DOI: https://doi.org/10.1038/nrd2503
This article is cited by
-
Concordance and predictive value of two adverse drug event data sets
BMC Medical Informatics and Decision Making (2014)